210 related articles for article (PubMed ID: 6123806)
1. Cyclosporin a as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Preliminary results of a European multicentre trial.
Lancet; 1982 Jul; 2(8289):57-60. PubMed ID: 6123806
[TBL] [Abstract][Full Text] [Related]
2. [Steroid-free treatment of renal transplant patients with cyclosporin A. A European multicentre study].
Beveridge T; Maurer W; Poole TW; Wood AJ; Wiskott E
Klin Wochenschr; 1982 Sep; 60(18):1137-42. PubMed ID: 6755046
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial.
Lancet; 1983 Oct; 2(8357):986-9. PubMed ID: 6138592
[TBL] [Abstract][Full Text] [Related]
4. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe?
Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE
S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A used alone or in combination with low-dose steroids in cadaveric renal transplantation.
Thiel G; Harder F; Lörtscher R; Brünisholz M; Landmann J; Brunner F; Follath F; Wenk M; Mihatsch M
Klin Wochenschr; 1983 Oct; 61(20):991-1000. PubMed ID: 6358654
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
[TBL] [Abstract][Full Text] [Related]
7. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression.
Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P
Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients.
Hoitsma AJ; Wetzels JF; van Lier HJ; Berden JH; Koene RA
Lancet; 1987 Mar; 1(8533):584-6. PubMed ID: 2881130
[TBL] [Abstract][Full Text] [Related]
9. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
Hourmant M; Soulillou JP
Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
[TBL] [Abstract][Full Text] [Related]
10. Ten-year experience with cyclosporine as primary immunosuppression in recipients of renal allografts.
Tilney NL; Chang A; Milford EL; Whitley WD; Lazarus JM; Ramos EL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1991 Jul; 214(1):42-9. PubMed ID: 2064470
[TBL] [Abstract][Full Text] [Related]
11. Improved patient and graft survival using cyclosporin A in cadaver renal transplantation.
Johnson RW
Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S81-5. PubMed ID: 3909587
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
Hall BM; Tiller DJ; Hardie I; Mahony J; Mathew T; Thatcher G; Miach P; Thomson N; Sheil AG
N Engl J Med; 1988 Jun; 318(23):1499-507. PubMed ID: 3285215
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients.
MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A
Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546
[TBL] [Abstract][Full Text] [Related]
14. Experience with cyclosporine and steroids in clinical renal transplantation.
Tilney NL; Milford EL; Araujo JL; Strom TB; Carpenter CB; Kirkman RL
Ann Surg; 1984 Nov; 200(5):605-13. PubMed ID: 6385881
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R
Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
[TBL] [Abstract][Full Text] [Related]
16. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine: five years' experience in cadaveric renal transplantation.
Merion RM; White DJ; Thiru S; Evans DB; Calne RY
N Engl J Med; 1984 Jan; 310(3):148-54. PubMed ID: 6361559
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation.
Morris PJ; Chapman JR; Allen RD; Ting A; Thompson JF; Dunnill MS; Wood RF
Lancet; 1987 Mar; 1(8533):586-91. PubMed ID: 2881131
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression by Cyclosporin A in human renal transplant recipients.
Ringdén O; Bergstrand A; Collste H; Grimfors G; Lundgren G; Groth CG
Scand J Urol Nephrol Suppl; 1981; 64():220-9. PubMed ID: 6755683
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A in cadaveric organ transplantation.
Calne RY; White DJ; Evans DB; Thiru S; Henderson RG; Hamilton DV; Rolles K; McMaster P; Duffy TJ; MacDougall BR; Williams R
Br Med J (Clin Res Ed); 1981 Mar; 282(6268):934-6. PubMed ID: 6781658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
